Welcome to our dedicated page for Harte-Hanks news (Ticker: HHS), a resource for investors and traders seeking the latest updates and insights on Harte-Hanks stock.
Harte-Hanks, Inc. (NASDAQ: HHS) is a prominent global customer experience company dedicated to enhancing customer engagement through comprehensive CX strategy, data-driven analytics, and actionable insights. Headquartered in Chelmsford, Massachusetts, Harte Hanks operates with a workforce of over 2,500 employees across the Americas, Europe, and Asia Pacific. The company operates through three primary business segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services.
Established over a century ago, Harte Hanks has consistently delivered results for clients worldwide by moving decision-makers beyond mere awareness to transactions and brand loyalty. The company’s notable clients include global brands such as Bank of America, GlaxoSmithKline, Unilever, Pfizer, HBOMax, Volvo, Ford, FedEx, Midea, Sony, and IBM.
In recent developments, Harte Hanks has demonstrated resilience and adaptability in a challenging economic environment. For the second quarter of 2023, the company reported revenues of $47.8 million, with the Customer Care segment experiencing growth that largely offset declines in other segments. However, a less favorable revenue mix led to a decrease in operating income to $1.7 million from $4.0 million in the same period of the previous year. Despite these challenges, Harte Hanks maintained a solid financial position with $13.4 million in cash and no outstanding debt as of June 30, 2023.
Kirk Davis, who became CEO in mid-2023, highlighted the importance of aligning the company’s cost structure and enhancing sales productivity. Key initiatives include a new partnership with a reputable business development company and the acquisition of InsideOut in December 2022, aimed at expanding lead generation capabilities. The company also executed its stock repurchase plan, buying back approximately 315,000 shares.
Recent leadership appointments, including Kelly Waller as Senior Vice President of Sales and Marketing and Ron Lee as Senior Vice President of Sales Services, underscore Harte Hanks’ commitment to revitalizing its growth strategy. The company’s transformative plan, dubbed “Elevate,” aims to enhance revenue growth, profitability, and operational efficiency. The plan includes collaborations with the Kearney consulting firm and a focus on leveraging data assets and technology to drive modern solutions for clients.
Financially, Harte Hanks reported a net income of $0.6 million for the second quarter of 2023, despite economic pressures and reduced client budgets. For the full year 2023, the company reported revenues of $191.5 million and ended the year with $18.4 million in cash. The extension of a $25 million credit line with Texas Capital Bank into 2025 further enhances Harte Hanks’ financial flexibility.
Harte Hanks continues to demonstrate a commitment to innovation and customer-centric solutions. As the company advances into its second century, it remains focused on driving sustainable, profitable growth through strategic sales initiatives, operational improvements, and a relentless commitment to customer satisfaction.
Harte Hanks (HHS) reported a 12% increase in Q1 revenues, reaching $49.0 million compared to $43.8 million in Q1 2021. The company achieved a net income of $3.3 million, reversing a net loss of $1.8 million from the prior year. Operating income improved to $3.9 million, up from an operating loss of $0.9 million. Growth was seen across all segments, particularly in Fulfillment & Logistics services, which saw a 28% increase. The company anticipates a $7.6 million NOL tax refund in 2022, supporting their liquidity.
Harte Hanks (Nasdaq: HHS) will release its financial results for Q1 2022 on May 12, 2022, following market close. A conference call is scheduled for the same day at 4:30 p.m. ET to discuss the results. The event will be accessible via webcast and telephone for interested parties. The company specializes in customer experience solutions, providing analytics and insights to help clients engage better with customers. Harte Hanks has a solid client base, including major brands such as Ford and Pfizer.
Harte Hanks (Nasdaq: HHS) has secured a contract with a multinational technology firm to enhance its B2B marketing through an omnichannel program. This agreement will leverage Harte Hanks' extensive experience in managing partner reseller initiatives, program strategy, media buying, and data analytics. CEO Brian Linscott emphasizes the focus on investing in technology and talent to foster growth for clients while optimizing their resources. The company boasts a long-term track record in delivering customer experience solutions across global markets.
Harte Hanks (Nasdaq: HHS) has announced its participation in the Noble Capital Markets' 18th Annual Investor Conference (NobleCon18) scheduled for April 20, 2022. The presentation will occur at 9:30 a.m. ET, at the Hard Rock Hotel & Casino in Hollywood, Florida. CEO Brian Linscott and CFO Lauri Kearnes will lead the discussion, with breakout sessions at 1:45 p.m. ET and 3:15 p.m. ET. Interested participants can register via Noble Capital Markets' website. A video webcast will be available the following day on Harte Hanks' investor relations site.
Harte Hanks (Nasdaq: HHS) partnered with a leading global financial services corporation to deliver over 300,000 at-home Covid-19 testing kits during the Omicron surge. Additionally, the company distributed more than 60,000 wellness kits containing hand sanitizers and PPE masks to its employees. This initiative was supported by their FDA-certified distribution center in Kansas City, allowing prompt delivery. The company emphasizes its significant investments in fulfillment facilities as a driver of growth amidst ongoing supply chain challenges.
Harte Hanks (HHS) reported a 10% revenue increase in Q4 2021, totaling $52.0 million, up from $47.1 million in Q4 2020. Diluted EPS rose to $0.20 from $0.11. Full-year revenues also improved by 10% to $194.6 million, while net income surged to $15.0 million compared to a net loss of $1.7 million in 2020. The company achieved an operating income of $7.6 million, reversing a previous loss. Cash and equivalents decreased to $15.1 million, but the company expects a $7.8 million tax refund to boost liquidity. CEO Brian Linscott emphasized sustainable profitability growth in 2022.
Harte Hanks, Inc. (Nasdaq: HHS) announced it will release its financial results for Q4 ended December 31, 2021, after the market closes on February 24, 2022. A conference call will follow at 4:30 p.m. ET to discuss the results. Interested parties can access the webcast online or via phone. The company specializes in customer experience strategies and analytics, serving clients like Bank of America and Pfizer, with over 2,500 employees in multiple regions.
Harte Hanks (Nasdaq: HHS) has secured a multi-year contract from a national healthcare organization to provide new mothers with essential products, including breast milk pumps and health-related materials. This initiative aligns with the Affordable Care Act's goal to enhance newborn nutrition. Over 100,000 breast milk kits are expected to be delivered in the first year. Harte Hanks was chosen for its comprehensive, cost-effective solutions and established relationship with the client, enabling efficient service delivery.
Harte Hanks (Nasdaq: HHS) announced the launch of an expanded healthcare practice, spearheaded by Janel Harris, an executive with extensive healthcare agency experience. The practice aims to leverage integrated services including patient insights and data analytics, enhancing client engagement in the healthcare sector. The company operates multiple distribution centers, including a new 400,000 square foot facility in Kansas City, fulfilling over 1.3 million packages annually. Harte Hanks continues to cater to major clients like GSK and Pfizer, aiming to provide comprehensive patient-centric solutions.
Harte Hanks (Nasdaq: HHS), a global customer experience company, will present at the Sidoti & Company Virtual Small-Cap Conference on January 20, 2022, at 10 a.m. ET. Management will also hold one-on-one meetings on January 19 and 20, 2022. Interested parties can access the presentation via webcast on the Harte Hanks investor relations website. For meeting requests, participants may contact their Sidoti representative or email hhs@fnkir.com.
FAQ
What is the current stock price of Harte-Hanks (HHS)?
What is the market cap of Harte-Hanks (HHS)?
What does Harte-Hanks, Inc. do?
What are the primary business segments of Harte-Hanks?
Who are some of Harte-Hanks' notable clients?
What were the financial results for Harte-Hanks in the second quarter of 2023?
Who is the CEO of Harte-Hanks?
What is the 'Elevate' plan?
How did Harte-Hanks perform financially in 2023?
What recent acquisitions has Harte-Hanks made?
What are the recent leadership changes at Harte-Hanks?
Does Harte-Hanks have any outstanding debt?
